404 related items for PubMed ID: 29507273
1. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM, Ezzat DA, Doudar NA, Adel M.
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[Abstract] [Full Text] [Related]
2. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[Abstract] [Full Text] [Related]
3. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
[Abstract] [Full Text] [Related]
4. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
[Abstract] [Full Text] [Related]
5. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
Pediatr Nephrol; 2015 Feb 23; 30(2):309-16. PubMed ID: 25142334
[Abstract] [Full Text] [Related]
6. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
Pediatr Nephrol; 2014 Aug 23; 29(8):1363-71. PubMed ID: 24263531
[Abstract] [Full Text] [Related]
7. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
Pediatr Nephrol; 2013 Dec 23; 28(12):2299-306. PubMed ID: 23949592
[Abstract] [Full Text] [Related]
8. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
Kidney Int; 2010 Aug 23; 78(3):296-302. PubMed ID: 20485332
[Abstract] [Full Text] [Related]
9. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct 23; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
10. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G, Venkatareddy M, Verma R, Segarra A, Cleuren AC, Martínez-Ramos A, Johnson RJ, Garg P.
Pediatr Nephrol; 2020 Oct 23; 35(10):1887-1896. PubMed ID: 32399663
[Abstract] [Full Text] [Related]
11. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
Rumana J, Hanif M, Muinuddin G, Maruf-Ul-Quader M.
Saudi J Kidney Dis Transpl; 2014 Jul 23; 25(4):830-6. PubMed ID: 24969196
[Abstract] [Full Text] [Related]
12. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ.
Pediatr Nephrol; 2018 Jul 23; 33(7):1101-1103. PubMed ID: 29492674
[Abstract] [Full Text] [Related]
13. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.
Am J Nephrol; 2000 Jul 23; 20(3):175-9. PubMed ID: 10878397
[Abstract] [Full Text] [Related]
14. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH.
PLoS One; 2017 Jul 23; 12(4):e0176198. PubMed ID: 28441404
[Abstract] [Full Text] [Related]
15. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH.
Pediatr Nephrol; 2014 Dec 23; 29(12):2333-40. PubMed ID: 25017621
[Abstract] [Full Text] [Related]
16. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J, Schenk H, Schiffer M.
Internist (Berl); 2019 May 23; 60(5):450-457. PubMed ID: 30887070
[Abstract] [Full Text] [Related]
17. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
Kurasawa S, Kato S, Ozeki T, Akiyama S, Ishimoto T, Mizuno M, Tsuboi N, Kato N, Kosugi T, Maruyama S, J-MARINE collaborators.
Clin Exp Nephrol; 2024 May 23; 28(5):431-439. PubMed ID: 38267800
[Abstract] [Full Text] [Related]
18. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
[Abstract] [Full Text] [Related]
19. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP, Chhabra P, Narayan G, Srivastava P, Prasad R, Singh A, Abhinay A, Batra VV.
Indian J Pediatr; 2019 Jan 03; 86(1):26-31. PubMed ID: 29968132
[Abstract] [Full Text] [Related]
20. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
Gong X, Huang J, Zhang Y, Wang F, Wang X, Meng L, Cheng X, Liu G, Cui Z, Zhao M.
Ren Fail; 2023 Jan 03; 45(2):2279642. PubMed ID: 37942512
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
